fda semaglutide compounding enforcement november 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Important Notice: Tirzepatide Compounding Update

Providers at Found evaluate patients for GLP-1 eligibility, prescribe medications like semaglutide or tirzepatide, and offer ongoing monitoring via telemedicine

GeneDx shares leap 50% o n non-GAAP profitability GeneDx (NASDAQ: WGS) shares enjoyed another strong surge, leaping 50% from $56.06 to $84.02 Tuesday after the company announced encouraging third-quarter results that included the achievement of a non-GAAP profitability milestone

In the STEP trials, semaglutide 2.4 mg weekly showed average weight reductions of 1215% of body weight over 68 weeks, whilst in the SCALE trials, liraglutide 3 mg daily typically produced 58% weight loss

Results at 4 Weeks This is when L-Carnitine starts showing visible fat-loss changes